 Renalytix AI PLC LON:RENX has seen its shares fall back after losses surged in the third quarter. The company, a developer of diagnostic solutions for kidney disease, said the net loss for the three months to the end of March came in at US8mln, compared to just US0.7mln for the same period in 2020. 